04/04
Headlines

Rexahn Pharmaceuticals

Top Wall Street Stories: China Sunergy (NASDAQ:CSUN), Twitter (NYSE:TWTR), Rexahn Pharmaceuticals (NYSEMKT:RNN), STR (NYSE:STRI), Hersha Hospitality (NYSE:HT)

John Meady03 mins

China Sunergy Co. Ltd. (NASDAQ:CSUN) belongs to Technology sector. Its net profit margin is -13.40% and weekly performance is -6.88%. On last trading day company shares ended up $2.98. China Sunergy Co. Ltd. (NASDAQ:CSUN) distance from 50-day simple moving average (SMA50) is -3.05%. Twitter Inc. (TWTR) announced today that it is expanding its Twitter Ads…

Read More

Shining on Major News: Rexahn Pharmaceuticals (NYSEMKT:RNN), Anadigics (NASDAQ:ANAD), Markit (NASDAQ:MRKT), Educational Development Corporation (NASDAQ:EDUC), Chindex International Inc. (NASDAQ:CHDX)

Colin Pettis02 mins

Rexahn Pharmaceuticals, Inc. (nyse mkt:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and financial results for the quarter ended June 30, 2014. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) belongs to Healthcare sector. Its weekly performance is 2.86%. On last trading day…

Read More

Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)

Colin Pettis04 mins

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) said, “We continue to enroll patients in each of our three clinical trials as expected, and as planned for. By the end of 2014, we expect to achieve key milestones in each trial. In Q4 we expect to have data from our Phase I trial of Supinoxin in cancer patients with…

Read More